Friday, 4 January 2013

Cellular Dynamics Announces Agreement with AstraZeneca

Yesterday, Cellular Dynamics International (CDI) released a press release announcing that they have reached an agreement with AstraZeneca. One of the goals of their agreement, is to collaborate for the development of new stem cell treatments based on induced pluripotent stem cells. About 15 days ago, CDI had also announced a partership with GE HealthCare Life Sciences

According to the agreement, AstraZeneca is licensed to commercially use CDI's "Icell" and "MyCell" products. Some of the purchased Icell products are:
  • iCell Cardiomyocytes
  • iCell Neurons
  • iCell Endothelial Cells
  • iCell Hepatocytes
AstraZenega wishes to use the products of the Icell and Mycell line to genetically engineer and manufacture cells from specific patient groups, for use as in vitro disease models.

Video about Cellular Dynamics

As part of their agreement, the two companies will also work together for the development of new types induced pluripotent stem cells. 

The financials terms of the agreement were not disclosed.

Promotional video of AstraZeneca

Read the official press release here

No comments:

Post a Comment

Please note that we dont offer any kind of medical advice. Questions requesting specific medical advice (e.g. where can I get this treatment, will this cure XXX condition, etc) will be published but most probably ignored by the administrators. :)

Note to spammers: You shall not pass. If you really want a link from us then consider making a stem cell related guest post !